In the cohort of patients with COVID-19, CAP1 and CAP2 subphenotypes assigned by the PCM differed by key clinical characteristics and revealed an interaction between corticosteroid treatment and mortality (P = 0.002). The gene discussed is CAP1; the disease is COVID-19.